Table 3.
MetS risk factors of participants at the screening, preintervention, and postintervention
| Criteriaa | Sex | Screening (%) | Preintervention (%) | Postintervention (%) |
|---|---|---|---|---|
| Waist circumference | Male | 6 (100) | 6 (100) | 6 (100) |
| Female | 11 (100) | 11 (100) | 11 (100) | |
| Serum HDL | Male | 6 (100) | 2 (33.3) | 3 (50) |
| Female | 7 (63.6) | 6 (54.5) | 5 (45.5) | |
| Fasting serum triglycerides | Male | 6 (100) | 2 (33.3) | 1 (16.7) |
| Female | 5 (45.5) | 3 (27.3) | 2 (18.2) | |
| Fasting blood glucose | Male | 5 (55.6) | 0 (0) | 0 (0) |
| Female | 3 (27.3) | 1 (9.0) | 0 (0) | |
| Blood pressure | Male | 1 (16.7) | 0 (0) | 0 (0) |
| Female | 1 (9.0) | 0 (0) | 0 (0) | |
| Total number | Total (means ± SD) | 51 (3.2 ± 0.6) | 31 (1.9 ± 0.6) | 28 (1.7 ± 0.8) |
Values for 17 subjects: female n = 11 and male n = 6.
Number and percentage of individuals meeting the following MetS criteria:
a
waist circumference >102 cm (men), or >88 cm (women); serum HDL <40 mg/dL (men) or <50 mg/dL (women); fasting blood glucose (women) ≥100 mg/dL; fasting serum triglycerides ≥150 mg/dL; blood pressure ≥130/85 mm Hg.